Key Points and Recommendations: Providers should continue to refer to the NIH and IDSA treatment guidelines for decisions regarding the multiple outpatient therapies available to treat patients with COVID-19. The two oral antiviral medications Paxlovid and molnupiravir are now being allocated... Continue Reading
Latest news information about the New Hampshire Medical Society.
On August 31, 2021, NH DHHS issued a health alert update on the recall of LeadCare blood lead tests.Key Points and Recommendations: Magellan Diagnostics, Inc. has expanded their product recall involving the LeadCare ® blood test kits. This expanded COOR-LO recall includes LeadCare® II... Continue Reading
Update # 44 mRNA COVID-19 Vaccine 3rd Dose Recommendations On August 13, 2021, NH DHHS issued a health alert on mRNA COVID-19 vaccine 3rd dose recommendations. Key Points and Recommendations: On August 12th, the U.S. Food and Drug Administration (FDA) authorized use of a 3rd dose of the... Continue Reading
On July 2, 2021, NH DHHS issued a health alert regarding NH’s lowering of the pediatric blood lead action level to 5 mcg/dL Key Points and Recommendations: Effective July 1, 2021, NH RSA 130-A, Lead Paint Poisoning Prevention and Control, lowers the NH public health action level for... Continue Reading
The New Hampshire medical community urges individuals, communities, schools and businesses to continue to follow Centers for Disease Control and NH Division of Public Health Services guidelines that highlight the efficacy of wearing masks in slowing the community transmission of COVID-19 in New... Continue Reading